Skip to content
Screener

Upstart Holdings, Inc. UPST Expense on convertible notes

Expense on convertible notes at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$0-100%
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$0-100%
GPA
General Purpose Acquisition Corp.GPAC
$366.79K
TeraWulf logo
TeraWulfWULF
$5.73B+1,045%
Finance of America Companies logo
Finance of America CompaniesFOA
$61.16M
Pegasystems logo
PegasystemsPEGA
$438.5K-54.0%

Segments

By segment

See full
Personal Lending-$19.87M-158%

Other financials

Income statement

See full
Revenue$364.7M+41.7%
Operating income$14.6M+222%
Net income$16.5M+195%
EPS (diluted)$0.16+220%

Balance sheet

See full
Cash & equivalents$456.0M-35.0%
Total debt$2.0B+37.6%
Total equity$797.5M+10.5%
Total assets$3.2B+28.0%

Cash flow

See full
Operating cash flow-$136.6M-13.7%
CapEx$2.1M+1,690%
Free cash flow-$138.7M-15.3%

Valuation

See full
Market cap$2.89B-55.2%
Enterprise value$4.46B-38.3%
P/E47.9×
P/S2.3×-5.3×

Profitability

See full
Operating margin4%+2.5pp
Net margin4.8%+4.3pp
FCF margin27%+16.9pp

Returns & leverage

See full
Return on equity7.9%+7.2pp
Debt / equity2.5×+0.5×

Where this comes from

Reported directly by Upstart Holdings, Inc. in its filing.

Tagged under the XBRL concept upst:IncomeExpenseOnConvertibleNotes.

The source filing: Upstart Holdings, Inc.’s 10-K, filed February 10, 2026.

Filed
Feb 10, 2026, 4:08 PM EST
Fiscal year
FY2025
Accession
0001647639-26-000027
Line itemYear Ended December 31, 2023Year Ended December 31, 20242025
Total operating expenses770,087809,3841,001,226
Income (loss) from operations(256,525)(172,856)42,631
Other income, net21,20618,79324,324
Expense on convertible notes(4,706)(7,694)(19,872)
Gain on debt extinguishment33,3617,246
Net income (loss) before income taxes(240,025)(128,396)54,329
Provision for income taxes107185728
Net income (loss)$(240,132)$(128,581)$53,601

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

FAQ

What is Upstart Holdings, Inc.'s expense on convertible notes?
Upstart Holdings, Inc. (UPST) reported expense on convertible notes of -$4.97M in Q4 2025.
How has Upstart Holdings, Inc.'s expense on convertible notes changed year-over-year?
Upstart Holdings, Inc.'s expense on convertible notes decreased by 158.3% year-over-year, from -$1.92M to -$4.97M.
What is the long-term trend for Upstart Holdings, Inc.'s expense on convertible notes?
Over 4 years (2021 to 2025), Upstart Holdings, Inc.'s expense on convertible notes has grown at a 78.1% compound annual growth rate (CAGR), from -$1.98M to -$19.87M.
What does expense on convertible notes mean?
This reflects the financial costs associated with the company's convertible debt instruments, including interest and non-cash amortization of debt discounts. It highlights the company's capital structure choices and the potential impact of debt servicing on net earnings. Investors monitor this to understand the cost of capital and the potential for future equity dilution.

Ask your AI about Upstart Holdings, Inc.'s expense on convertible notes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude